Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001966716-26-000012

GENERAL COUNSEL & CORP SEC sold 2,861 shares at an average $32.03 ($91,639)

  • GENERAL COUNSEL & CORP SEC acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Allan Jonathan · GENERAL COUNSEL & CORP SEC

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-14 Exercise or conversion : show line 1 in the form +6,000 24,086 D
2026-08-18 Sale : show line 2 in the form −2,716 $32.01 $86,932 21,370 D
2026-08-18 Sale : show line 3 in the form −145 $32.47 $4,708 21,225 D
Open-market sales · 2,861 sh · avg $32.03 · $91,639

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-14 Exercise or conversion : show line 4 in the form Performance Stock Units −6,000 0 D
Loading xslF345X06/form4-08192026_120818.xml…